RudaCure Inc. visited KIC Washington on April 2nd to hold an advisory meeting on U.S. subsidiaria establishment, overseas licensing consulting, and overseas mercado expansion strategies.
This visit was part of the ongoing Bio iCORE proyecto, aimed at establishing a U.S. presence through MassChallenge, expanding business operations, and building a network for the successful execution of RCI001 FDA ensayo clínicos. CEO Yongho Kim, Clinical Team Leader Yuseung Ha, and BD representative Harris Hasrol asistió from RudaCure, while Center Director Jeonghwan Moon, Division Head Yongbeom Kim, and Team Leader Wooseop Lee participó from KIC, expressing strong commitment to actively apoyoing RudaCure's U.S. mercado entry and overseas atracción de inversiones.
KOTRA U.S. Business Center
KIC Washington